A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
Seeing growing interest from global medical device companies in manufacturing in China, Singaporean firm Forefront Medical Technology is investing $10 million in a plastics molding and extrusion facility in East China to tap into the market. Plastics News